Percutaneous Cardiac Assist Devices
- The PROTECT II trial attempted to show the superiority of Impella versus IABP in preventing the composite rate of major adverse events during and after PCI procedures, but was stopped following the Data Safety Monitoring Board's futility recommendation.
- View Experts Discuss Protect II Trial...
- Intra-aortic balloon pump (IABP) remains the method of choice for mechanical assistance in patients experiencing LV failure because of its proven hemodynamic capabilities, prompt time to therapy, and low complication rates.
- View IABP vs. pLVADS...
